Tempus ECG-AF vs KardiaPro
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to proactively identify elderly patients (65+) in a clinical setting who are at an increased risk of developing new-onset atrial fibrillation within the next 12 months. This tool is ideal for integrating into existing 12-lead ECG workflows to support earlier intervention and follow-up for at-risk individuals without a prior AF diagnosis.
View Tempus ECG-AF →Choose KardiaPro if…
Choose KardiaPro if you need a comprehensive, web-based platform for remote monitoring of patients with known or suspected cardiac conditions, including arrhythmia detection. This tool is best suited for managing and reviewing longitudinal ECG, blood pressure, and weight data from compatible personal devices, enabling efficient trend analysis and informed clinical decision-making between appointments.
View KardiaPro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | KardiaPro |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | Cloud-hosted, Web-based |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaProKardiaPro offers a comprehensive web-based portal for remote monitoring, enabling healthcare professionals to easily manage and review patient data, customize their ECG inbox, and visualize trends. Tempus ECG-AF, while integrated into healthcare facility systems, is primarily an algorithm without a dedicated user interface, suggesting a less direct user experience for clinicians.
Clinical Value
KardiaProKardiaPro's FDA-cleared AI detects up to 35 rhythms and morphologies, and it integrates with devices for ECG, blood pressure, and weight data, offering a broader scope of cardiac monitoring and diagnostic support. Tempus ECG-AF focuses specifically on predicting the 12-month risk of AF/flutter in a defined patient population, which is valuable but narrower in scope.
Pricing & Value
Tempus ECG-AFTempus ECG-AF has clear CMS reimbursement available with specific CPT codes and a Medicare rate, offering transparency and a defined path for financial viability for healthcare facilities. KardiaPro states it's reimbursable using existing CPT codes but directs users to contact the vendor for specific pricing, making its value proposition less immediately transparent.
Enterprise Readiness
KardiaProKardiaPro offers various integration technologies, including an SDK and API, and has demonstrated integration with Epic EHR via its App Orchard Marketplace, indicating strong enterprise readiness. Tempus ECG-AF is a software solution integrated into healthcare facility systems and compatible with specific ECG devices, but its broader enterprise integration capabilities are less explicitly detailed.
Innovation
KardiaProKardiaPro, through AliveCor, has a history of pioneering FDA-cleared mobile ECG technology and AI-powered cardiac solutions, including the first 6-lead personal ECG and a handheld 12-lead ECG system. Tempus ECG-AF represents an innovative application of AI for AF risk prediction, but AliveCor's broader portfolio and historical impact suggest a wider innovative footprint in personal cardiac care.
Support & Docs
TieBoth tools provide avenues for support and documentation. KardiaPro offers user guides, FAQs, and direct contact information for support. Tempus ECG-AF provides technical support contact information. Without more detailed information on the breadth and accessibility of their documentation and support services, it's difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | KardiaPro |
|---|---|---|
| Tool Name | Tempus ECG-AF | KardiaPro |
| Company | Tempus AI, Inc. | AliveCor |
| Description | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. | Comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations. |
| Key Features | AI-based algorithm for 12-lead ECG analysis; Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months; Intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery; Results interpreted in conjunction with other diagnostic information and clinical history; Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems; Trained on over 1.5 million ECGs from over 500,000 patients | Comprehensive web-based portal for remote monitoring; ECG, blood pressure, and weight data management; FDA-cleared AI for arrhythmia detection; Customizable ECG inbox for efficient data review; Automated summary reports and trend visualization; Seamless integration with KardiaMobile and KardiaMobile 6L devices; Integration with KardiaStation for point-of-care solutions; HIPAA-compliant and SOC-2 certified data handling |
| Specialties | Cardiology, Geriatrics, Internal Medicine | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and KardiaPro.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-AF or KardiaPro
Backers
Who funded each tool's parent company.